Abstract
Background aims. Bone marrow-derived mesenchymal stromal cells (BMSC) have been shown to migrate to injury, ischemia and tumor microenvironments. The mechanisms by which mesenchymal stromal cells (MSC) migrate across endothelium and home to the target tissues are not yet fully understood. Methods. We used rat BMSC to investigate the molecular mechanisms involved in their tropism to tumors in vitro and in vivo. Results. BMSC were shown to migrate toward four different tumor cells in vitro, and home to both subcutaneous and lung metastatic prostate tumor models in vivo. Gene expression profiles of MSC exposed to conditioned medium (CM) of various tumor cells were compared and revealed that matrix metalloproteinase-2 (MMP-2) expression in BMSC was downregulated after 24 h exposure to tumor CM. Chemokine (C–X–C motif) Receptor 4 (CXCR4) upregulation was also found in BMSC after 24 h exposure to tumor CM. Exposure to tumor cell CM enhanced migration of BMSC toward tumor cells. Stromal Cell-Derived Factor (SDF-1) inhibitor AMD3100 and MMP-2 inhibitor partly abolished the BMSC migration toward tumor cells in vitro. Conclusions. These results suggest that the CXCR4 and MMP-2 are involved in the multistep migration processes of BMSC tropism to tumors.
Acknowledgement
We acknowledge the financial support of China Natural Science Foundation (grant number 30872635/C160705) to GL, Hong Kong Innovation Technology Commission (grant reference ITS/09/305) to GL and a Direct Research Grant from The Medical Faculty, The Chinese University of Hong Kong (2041522) to GL.
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
